Sirexatamab in Combination with Bevacizumab and Chemotherapy as Second-Line Therapy for Advanced Colorectal Adenocarcinoma: the Phase II DeFianCe Trial. - Wainberg ZA; Lee KW; Kim JG; Devoe C; Strickler JH; Baum J; Jia C; Kagey MH; Sirard CA; Stein A; Scott AJ; Pelster M; et al. (Clinical cancer research : an official journal of the American Association for Cancer Research, 2026)